𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose-toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients

✍ Scribed by Bente T. Sørensen; Annette Strömgren; Preben Jakobsen; Anders Jakobsen

Publisher
Springer
Year
1991
Tongue
English
Weight
492 KB
Volume
28
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose intensive combination platinum and
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer
✍ Jeremy D. Shapiro; Mace L. Rothenberg; Gisele A. Sarosy; Seth M. Steinberg; Debr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## BACKGROUND. The authors combined cisplatin and carboplatin together with cyclophosphamide to maximize platinum dose intensity in patients with advanced epithelial ovarian cancer (AOC). ## METHODS. The authors treated 26 consecutive, newly diagnosed patients with International Federation of G

The disposition of carboplatin in ovaria
The disposition of carboplatin in ovarian cancer patients
✍ Robert C. Gaver; Nicoletta Colombo; Michael D. Green; Alice M. George; George De 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 908 KB

Carboplatin was given as a 30-min infusion to 11 ovarian cancer patients at doses of 170-500 mg/m 2. The ages, weights, and creatinine clearances (Clef) ranged from 44 to 75 years, from 44 to 74 kg, and from 32 to 101 ml/ min, respectively. Plasma, plasma ultrafiltrate (PU), and urine samples were o